Developmental Mechanisms Underlying Risk Behaviors and Their Treatment
Developmental Mechanisms Underlying Risk Behaviors and Their Treatment
批准号:
8820083
负责人:
SUSAN L ANDERSEN
金额:
$33.36万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-06-15 至 2016-03-31
关键词:
AcuteAddressAdolescenceAdolescentAdultAgeAgonistAmygdaloid structureAttention deficit hyperactivity disorderBehaviorBehavioralBioinformaticsBrainCellsComplexConfocal MicroscopyCoupledDataDevelopmentDopamineDopamine D1 ReceptorDoseDrug ExposureDrug effect disorderEffectivenessExcitotoxic lesionExposure toFemaleFunctional disorderGene ExpressionGenesGenetic EngineeringGlutamatesGoalsImpairmentImpulsive BehaviorImpulsivityIndividualInterventionKnowledgeLasersLeadLentivirus VectorLifeLong-Term EffectsMediatingMessenger RNAMethylphenidateMicroRNAsMicrodissectionMicroinjectionsModificationMolecularMotorNeural PathwaysNeuronsNorepinephrineNucleus AccumbensPathological GamblingPathologyPathway interactionsPharmaceutical PreparationsPopulationPrefrontal CortexPreventionPrevention approachRattusReaction TimeResearchRewardsRisk BehaviorsRodentRunningSamplingSex CharacteristicsSignal PathwaySignal TransductionTechniquesTestingTherapeuticTimeTissuesTracerViralViral VectorWestern BlottingWorkatomoxetinebasedifferential expressiondiscountingeffective interventioneffective therapyfrontal lobemaleneural circuitneuronal circuitrynoradrenergicnovelnovel markerpreventprotein expressionreceptorsextool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This application examines the underlying signaling mechanisms that are involved in impulsivity as it changes across development (juvenile, adolescent, and adult), sex, pathology, and drug exposure. The overarching goal of this application is to: To identify dysfunctional neuronal circuit(s) and signaling mechanisms associated with impulsive behaviors and identify novel prevention approaches for intervention. We propose a multi-faceted approach that encompasses behavioral and molecular analyses to examine neuronal function within well-defined neural pathways in the rodent brain of both males and females. We have two Co-PIs, who will be running different aspects of these projects indepdently and interdependently at various times within the 5 year period. We build on our new data that show that elevated D1 dopamine receptors in the prelimbic prefrontal cortex of the rat increase impulsivity and other risky behaviors. Aim 1 will identify and confirm neuronal pathways underlying impulsivity using both a reward-associated impulsivity task of impulsive choice (e.g., delayed discounting) and a motor-related task of impulsive action (e.g., the stop signal reaction time task). We will analyze receptors on projections from the prelimbic prefrontal cortex, the basolateral amygdala, and the orbital frontal cortex as they innervate the nucleus accumbens and the basolateral amygdala. Differential expression levels of D1 and alpha2A noradrenergic receptors are hypothesized to mediate these behaviors. We will use laser microdissection (LMD) and quantitative, real-time PCR for this initial assessment, followed by mechanistic confirmation with experimental use of viral vectors that selectively over-express these receptors in glutamate neurons in a given region. In Aim 2, we will determine effective doses (ED50s) of methylphenidate, atomoxetine, and guanficine on impulsivity at different ages and across sex. Due to their different selectivity for dopamine and alpha2A receptors, we expect that different signaling pathways will be uniquely activated at different ages. The derived ED50s will then be used in a juvenile exposure paradigm that is predicted to effectively prevent impulsive behaviors in adulthood. In Aim 3, samples from Aim 1 (viral over-expression) and Aim 2 (preventative interventions) will be analyzed with a bioinformatics approach with microarray and microRNAs analyses to identify convergent signaling pathways involved in impulsive behaviors and its effective intervention. Together, these studies will provide information on the developmental profile of the mechanisms underlying impulsivity as it is influenced by sex and medication.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Development of near-infrared spectroscopy to study drug addiction
-
批准号:8680199
-
项目类别:
-
资助金额:$18.36万
-
财政年份:2013
-
负责人:SUSAN L ANDERSEN
-
依托单位:
Development of near-infrared spectroscopy to study drug addiction
-
批准号:8600477
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2013
-
负责人:SUSAN L ANDERSEN
-
依托单位:
Developmental Mechanisms Underlying Risk Behaviors and Their Treatment
-
批准号:8442936
-
项目类别:
-
资助金额:$32.02万
-
财政年份:2011
-
负责人:SUSAN L ANDERSEN
-
依托单位:
Sensitive periods, development, and substance abuse
-
批准号:8776936
-
项目类别:
-
资助金额:$35.02万
-
财政年份:2011
-
负责人:SUSAN L ANDERSEN
-
依托单位:
Sensitive periods, development, and substance abuse
-
批准号:8574130
-
项目类别:
-
资助金额:$35.55万
-
财政年份:2011
-
负责人:SUSAN L ANDERSEN
-
依托单位:
Sensitive periods, development, and substance abuse
-
批准号:8374424
-
项目类别:
-
资助金额:$34.13万
-
财政年份:2011
-
负责人:SUSAN L ANDERSEN
-
依托单位:
Sensitive periods, development, and substance abuse
-
批准号:8038586
-
项目类别:
-
资助金额:$34.87万
-
财政年份:2011
-
负责人:SUSAN L ANDERSEN
-
依托单位:
Developmental Mechanisms Underlying Risk Behaviors and Their Treatment
-
批准号:8645745
-
项目类别:
-
资助金额:$33.36万
-
财政年份:2011
-
负责人:SUSAN L ANDERSEN
-
依托单位:
Developmental Mechanisms Underlying Risk Behaviors and Their Treatment
-
批准号:8278493
-
项目类别:
-
资助金额:$33.36万
-
财政年份:2011
-
负责人:SUSAN L ANDERSEN
-
依托单位:
Sensitive periods, development, and substance abuse
-
批准号:8207888
-
项目类别:
-
资助金额:$35.55万
-
财政年份:2011
-
负责人:SUSAN L ANDERSEN
-
依托单位:
Developmental Mechanisms Underlying Risk Behaviors and Their Treatment
-
批准号:8108398
-
项目类别:
-
资助金额:$48.16万
-
财政年份:2011
-
负责人:SUSAN L ANDERSEN
-
依托单位:
Translational Imaging of Methylphenidate Exposure
-
批准号:6674987
-
项目类别:
-
资助金额:$14.35万
-
财政年份:2003
-
负责人:SUSAN L ANDERSEN
-
依托单位:
Early Drug Exposure and Drug Reward Mechanisms
-
批准号:6720927
-
项目类别:
-
资助金额:$20.76万
-
财政年份:2003
-
负责人:SUSAN L ANDERSEN
-
依托单位:
Early Drug Exposure and Drug Reward Mechanisms
-
批准号:6805983
-
项目类别:
-
资助金额:$22.2万
-
财政年份:2003
-
负责人:SUSAN L ANDERSEN
-
依托单位:
Early Drug Exposure and Drug Reward Mechanisms
-
批准号:8012866
-
项目类别:
-
资助金额:$30.65万
-
财政年份:2003
-
负责人:SUSAN L ANDERSEN
-
依托单位:
Early Drug Exposure and Drug Reward Mechanisms
-
批准号:8415540
-
项目类别:
-
资助金额:$29.43万
-
财政年份:2003
-
负责人:SUSAN L ANDERSEN
-
依托单位:
Early Drug Exposure and Drug Reward Mechanisms
-
批准号:7076912
-
项目类别:
-
资助金额:$19.18万
-
财政年份:2003
-
负责人:SUSAN L ANDERSEN
-
依托单位:
Early Drug Exposure and Drug Reward Mechanisms
-
批准号:7253287
-
项目类别:
-
资助金额:$18.73万
-
财政年份:2003
-
负责人:SUSAN L ANDERSEN
-
依托单位:
Early Drug Exposure and Drug Reward Mechanisms
-
批准号:6921503
-
项目类别:
-
资助金额:$19.68万
-
财政年份:2003
-
负责人:SUSAN L ANDERSEN
-
依托单位:
Early Drug Exposure and Drug Reward Mechanisms
-
批准号:8211086
-
项目类别:
-
资助金额:$30.65万
-
财政年份:2003
-
负责人:SUSAN L ANDERSEN
-
依托单位:
海外基金